U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07286357) titled 'A Multi-Center Retrospective Data Collection Protocol to Evaluate the Real World Usage of the Orthofix AccelStim Device to Treat Fresh Metatarsal Fractures' on Dec. 03.
Brief Summary: This study examines the effect of using the AccelStim bone growth stimulator on subjects undergoing treatment for fresh metatarsal fractures.
Study Start Date: May 30
Study Type: OBSERVATIONAL
Condition:
Metatarsal Fracture
Intervention:
DEVICE: AccelStim (LIPUS)
Subjects treated with LIPUS were directed to use the AccelStim device for 20 minutes per day, up to 6 months or until no longer needed.
Recruitment Status: ACTIVE_NOT_RECRUITING
Spons...